Will This Analyst Upgrade Help Envision Healthcare (EVHC) Stock Today?

NEW YORK (TheStreet) -- Goldman Sachs upgraded Envision Healthcare  (EVHC) to "buy" from "neutral," set a $43 price target and placed the stock on its Conviction List. The firm noted the company's outlook is improving and it trades at a compelling valuation.

The stock closed at $35.95 on Friday.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EVHC Chart

EVHC data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Federal Reserve, Oracle, T-Mobile, Les Moonves and J&J - 5 Things You Must Know

Federal Reserve, Oracle, T-Mobile, Les Moonves and J&J - 5 Things You Must Know

Jim Cramer: Oracle Is Yet Another Victim of This Traitorous Market

Jim Cramer: Oracle Is Yet Another Victim of This Traitorous Market

The Longest Bull Market: History and Facts in 2018

The Longest Bull Market: History and Facts in 2018

Market of the Week with Dan Gramza: Silver Futures

Market of the Week with Dan Gramza: Silver Futures

Monday Madness: Johnson & Johnson Is Still Making Headlines

Monday Madness: Johnson & Johnson Is Still Making Headlines